Klaviyo director converts 16,775 Series B shares
Klaviyo, Inc. director Roxanne Oulman reported a class-for-class conversion on July 22, 2026, in which the Roxanne Oulman 2025 GRAT converted 16,775 shares of Series B Common Stock into the same number of Series A shares.
Rhea-AI Filing Summary
Klaviyo, Inc. director Roxanne Oulman reported a class-for-class conversion on July 22, 2026, in which the Roxanne Oulman 2025 GRAT converted 16,775 shares of Series B Common Stock into the same number of Series A shares. After this, the GRAT indirectly holds 29,891 Series B and 16,775 Series A shares. Oulman also reports direct positions of 15,165 Series B and Series A-related holdings totaling 37,343 shares/units, consisting of 22,521 Series A shares and 14,822 unvested restricted stock units. She disclaims beneficial ownership of the GRAT-held shares except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
16,775 shares exercised/converted
Exercise
4 txns
Insider
Oulman Roxanne
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series B Common Stock F1, F2 | 16,775 | $0.00 | $0.00 |
| Conversion | Series A Common Stock F1, F2 | 16,775 | -- | -- |
| holding | Series B Common Stock F1 | -- | -- | -- |
| holding | Series A Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Series B Common Stock — 29,891 contracts (Indirect, By Roxanne Oulman 2025 GRAT);
Series A Common Stock — 16,775 shares (Indirect, By Roxanne Oulman 2025 GRAT);
Series B Common Stock — 15,165 contracts (Direct);
Series A Common Stock — 37,343 shares (Direct)
Footnotes (3)
- F1. Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
- F2. Shares held by Roxanne Oulman 2025 GRAT, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- F3. Consists of (i) 22,521 shares of Series A Common Stock and (ii) 14,822 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.
Key Figures
Shares converted: 16,775 shares
Indirect Series B via GRAT: 29,891 shares
Indirect Series A via GRAT: 16,775 shares
+3 more
6 metrics
Shares converted
16,775 shares
Series B Common Stock converted into Series A Common Stock on July 22, 2026
Indirect Series B via GRAT
29,891 shares
Series B Common Stock indirectly held by Roxanne Oulman 2025 GRAT after conversion
Indirect Series A via GRAT
16,775 shares
Series A Common Stock indirectly held by Roxanne Oulman 2025 GRAT after conversion
Direct Series B holdings
15,165 shares
Series B Common Stock directly held, convertible into Series A on a 1:1 basis
Direct Series A shares and RSUs
37,343 shares/units
Consists of 22,521 Series A shares and 14,822 unvested restricted stock units
Unvested restricted stock units
14,822 units
RSUs each representing the contingent right to receive one Series A share upon vesting
Key Terms
Series B Common Stock, Series A Common Stock, restricted stock units, GRAT
4 terms
Series B Common Stock financial
"Each share of the Issuer's Series B Common Stock is convertible into Series A"
Series A Common Stock financial
"Convertible at any time into one share of the Issuer's Series A Common Stock"
Series A common stock is a specific class of a company’s ordinary shares issued during an early formal funding round, carrying the ownership rights and voting power tied to that class. For investors it signals an early-stage equity claim with potential upside if the business grows, but also greater risk and typically less liquidity than shares in mature, publicly traded firms—imagine buying a seat on a startup’s team before the company has proven itself.
restricted stock units financial
"Includes 14,822 unvested restricted stock units under the 2023 Stock Option and Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
GRAT financial
"Shares held by Roxanne Oulman 2025 GRAT, of which the Reporting Person serves as trustee"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What direct Klaviyo (KVYO) holdings does director Roxanne Oulman report?
Oulman reports direct holdings of 15,165 shares of Klaviyo Series B Common Stock and Series A-related holdings totaling 37,343 shares/units. The 37,343 figure consists of 22,521 Series A shares and 14,822 unvested restricted stock units awarded under Klaviyo’s 2023 equity plan.
Was Roxanne Oulman’s Klaviyo (KVYO) conversion under a Rule 10b5-1 plan?
The Form 4 indicates the Rule 10b5-1 trading plan checkbox was not marked and the footnotes do not describe any such plan. Accordingly, the reported share conversion is not described as occurring pursuant to a pre-arranged Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
